Nabros Pharma Private Limited, a active private limited company, was established on 29 December 1983 in Ahmadabad City, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ1983PTC006628. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹4.70 M.
It upholds a compliant status. Employing 48 professional, Its leadership includes Narendrakumar Laxmansingh Darbar (Managing Director), Amit Navnitbhai Shah (Director), Kavit Muktikumar Shah (Whole-Time Director). Past directors included Samir Dasrathbhai Bhavsar, Narendrakumar Laxmansingh Darbar, Amit Navnitbhai Shah. It holds ₹4.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3Rd Floor, Oriental House-Ii, Opp. Art Gallery, B/H. British Library, Law Garden,, Ahmadabad City, Gujarat, 380006.
U24230GJ1983PTC006628
006628
29 December 1983
₹1.00 Cr
₹4.70 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Nabros Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narendrakumar Laxmansingh Darbar | Managing Director | 11 Apr 2024 | Current |
| Amit Navnitbhai Shah | Director | 11 Apr 2024 | Current |
| Kavit Muktikumar Shah | Whole-Time Director | 05 Apr 2009 | Current |
| Chandrikaben Navnitlal Shah | Whole-Time Director | 29 Oct 1984 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2016 | Past |
| Pramod Abcsdd | Additional Director | 19 Apr 2024 | Past |
| Pramod Abcsdd | Additional Director | 19 Apr 2024 | Past |
| Pramod Abcsdd | Whole-Time Director | 22 Sep 2008 | Past |
| Pramod Abcsdd | Whole-Time Director | 05 Apr 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nabros Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.82% increase. The company also saw a substantial improvement in profitability, with a 10.61% increase in profit. The company's net worth moved up by a moderate rise of 9.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nabros Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 1997 | Canara Bank | ₹4.50 M | Open |
Explore comprehensive loan charge details -
Nabros Pharma has a workforce of 48 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nabros Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nabros Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nabros Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Narendrakumar Laxmansingh Darbar was appointed as a Managing Director was appointed as a Managing Director on 11 Apr 2024 & has been associated with this company since 1 year 8 months . was documented.
Progress on Amit Navnitbhai Shah was appointed as a Director was appointed as a Director on 11 Apr 2024 & has been associated with this company since 1 year 8 months . was documented.
Nabros Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
The activity Kavit Muktikumar Shah was appointed as a Whole-time director was appointed as a Whole-time director on 05 Apr 2009 & has been associated with this company since 16 years 8 months . was completed.
Progress on A charge with Canara Bank amounted to Rs. 0.45 Cr with Charge ID 90112405 was registered on 30 Dec 1997. was documented.
The CIN of Nabros Pharma Private Limited is U24230GJ1983PTC006628.
Nabros Pharma Private Limited is headquartered at 3Rd Floor, Oriental House-Ii, Opp. Art Gallery, B/H. British Library, Law Garden,, Ahmadabad City, Gujarat, 380006.
Nabros Pharma Private Limited was incorporated on 29 December 1983.
The current directors of Nabros Pharma Private Limited are
The primary industry of Nabros Pharma Private Limited is Manufacturing.
Nabros Pharma Private Limited is unlisted.
The authorized capital of Nabros Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹4.70 M.
The compliance status of Nabros Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX